Increasing Incidence of Sternoclavicular Joint Infections in Intravenous Drug Users

Abstract

Sternoclavicular joint septic arthritis is rarely seen in the general population. The majority of cases are seen in intravenous drug users. Given the lack of reported cases in the literature, there is no standardized treatment algorithm for this disease. Described treatment methods range from medical management to wide local debridement. The incidence of sternoclavicular joint septic arthritis will likely continue to increase with rising usage of intravenous drugs in the United States. Within the past year, our institution treated four cases.

Keywords

infection - sternum - chest wall

Publikationsverlauf

Eingereicht: 21. März 2021

Angenommen: 28. Oktober 2021

Artikel online veröffentlicht:
17. Januar 2022

• References

• 1 Ross JJ, Shamsuddin H. Sternoclavicular septic arthritis: review of 180 cases. Medicine (Baltimore) 2004; 83 (03) 139-148
• 2 Fordham S, Cope S, Sach M. Optimal management of sternoclavicular septic arthritis. Eur J Emerg Med 2009; 16 (04) 219-220
• 3 Burkhart HM, Deschamps C, Allen MS, Nichols III FC, Miller DL, Pairolero PC. Surgical management of sternoclavicular joint infections. J Thorac Cardiovasc Surg 2003; 125 (04) 945-949
• 4 Alexander PW, Shin MS. CT manifestation of sternoclavicular pyarthrosis in patients with intravenous drug abuse. J Comput Assist Tomogr 1990; 14 (01) 104-106
• 5 Abu Arab W, Khadragui I, Echave V, Deshaies A, Sirois C, Sirois M. Surgical management of sternoclavicular joint infection. Eur J Cardiothorac Surg 2011; 40 (03) 630-634
• 6 Jang YR, Kim T, Kim MC. et al. Sternoclavicular septic arthritis caused by Staphylococcus aureus: excellent results from medical treatment and limited surgery. Infect Dis (Lond) 2019; 51 (09) 694-700
• 7 Puri V, Meyers BF, Kreisel D. et al. Sternoclavicular joint infection: a comparison of two surgical approaches. Ann Thorac Surg 2011; 91 (01) 257-261